☆ 4.7 Meeting Abstract

Overcoming the Safety Challenges of Aldose Reductase Inhibition: Development of AT-001 for Diabetic Cardiomyopathy

METABOLISM-CLINICAL AND EXPERIMENTAL (2020)

Get Full Text
Add to Collection

Journal

METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 104, Issue -, Pages -

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2019.12.060

Keywords

AT-001; Diabetic Cardiomyopathy; Aldol Reductase Inhibitor; Heart Failure

Categories

Endocrinology & Metabolism

Funding

  1. Applied Therapeutics Inc

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.